[Federal Register Volume 83, Number 26 (Wednesday, February 7, 2018)]
[Notices]
[Page 5465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-02375]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes; Meeting
Notice
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The U.S. Nuclear Regulatory Commission will convene a meeting of
the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March
7-8, 2018. A sample of agenda items to be discussed during the public
session includes: (1) A discussion on medical-related events; (2) an
update on the worldwide supply and domestic production of molybdenum-
99; (3) a discussion on the resources needed to address the development
of emerging medical technologies; and (4) a discussion of staff's
evaluation of the ACMUI's recommendations related to medical event
reporting under title 10 Code of Federal Regulations (10 CFR) 35.3045
and impact on safety culture at medical institutions. The agenda is
subject to change. The current agenda and any updates will be available
at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html or by emailing Ms. Sophie Holiday at the contact information
below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Sessions: March 7, 2018, from 8:30 a.m. to
2:30 p.m. and March 8, 2018, from 8:30 a.m. to 2:45 p.m. Eastern
Standard Time.
Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two
White Flint North Building, Room T2-B3, 11545 Rockville Pike,
Rockville, Maryland 20852.
Public Participation: Any member of the public who wishes to
participate in the meeting in person or via phone should contact Ms.
Holiday using the information below. The meeting will also be webcast
live at https://video.nrc.gov/.
Contact Information: Sophie Holiday, email: [email protected],
telephone: (301) 415-7865.
Conduct of the Meeting
Philip O. Alderson, M.D. will chair the meeting. Dr. Alderson will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Holiday using the contact information listed
above. All submittals must be received by March 2, 2018, three business
days before the meeting, and must pertain to the topics on the agenda
for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html on or about April 19, 2018.
4. Persons who require special services, such as those for the
hearing impaired, should notify Ms. Holiday of their planned
attendance.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in 10
CFR part 7.
Dated at Rockville, Maryland this 1st day of February, 2018.
For the Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2018-02375 Filed 2-6-18; 8:45 am]
BILLING CODE 7590-01-P